Investigation of a Novel Cosmeceutical to Reduce the Visible Signs of Cutaneous Aging (REDUCEAGE)

Tomorrowlabs

Status and phase: Unknown; Phase 2; Phase 1

Conditions: Aging

Treatments: Other: Tomorrowlabs cosmeceutical formulation; Other: Sham cosmeceutical formulation

Study type: Interventional

Funder types: Industry

Identifiers

NCT02877758

TMRW-CTa

Details and patient eligibility

About

Tomorrowlabs has developed a revolutionary cosmeceutical formulation to rejuvenate aging skin. Tomorrowlabs is conducting this research to study whether this cosmeceutical can reduce the visible signs of cutaneous aging.

Full description

It is proposed to study a cosmeceutical formulation designed to reduce the visible signs of cutaneous aging. It is expected that daily application of the formulation may minimize wrinkles and fine lines of the face.

Enrollment: 40 estimated patients

Sex: All

Ages: 30 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy volunteers who desire to improve their appearance by reducing the visible signs of cutaneous aging in the face

Exclusion criteria

• Subjects who have undergone facial plastic surgery or aesthetic dermatology treatments to the face (such as fillers and neuromodulators) in the past 6 months
• Subjects with a history of collagen vascular disease, cutis laxa, connective tissue disease, psoriasis, or lupus.
• Subjects diagnosed with scleroderma.
• Subjects with a body mass index (BMI) > 30.
• Subjects taking steroid therapy.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

40 participants in 2 patient groups

Experimental

Experimental group

Description:

Tomorrowlabs cosmeceutical formulation is applied to the face of the subjects twice daily for 3 consecutive months.

Treatment:

Other: Tomorrowlabs cosmeceutical formulation

Control

Sham Comparator group

Description:

Tomorrowlabs cosmeceutical formulation without the active ingredient is applied to the face of the subjects twice daily for 3 consecutive months.

Treatment:

Other: Sham cosmeceutical formulation